Clinical trials
Light clinical trials
Below are recruiting light clinical trials, each written for real people, not researchers. We’re tracking 277 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05978661RecruitingPhase 1
FKC288 cell therapy for AL amyloidosis
This trial tests a new cell therapy called FKC288 for people with AL amyloidosis that hasn't been helped by standard treatments. The goal is to see if it can safely control the disease and improve organ function.
Nanjing, JiangsuAges 18–70 - NCT06046118Recruiting
Light therapy for dry age-related macular degeneration
This trial tests whether a special light treatment (photobiomodulation) can help people with dry age-related macular degeneration (AMD). It is designed for those with early to moderate dry AMD who still have fairly good vision.
ParisAges 50 years+ - NCT06158854RecruitingPhase 1/Phase 2
Study of etentamig (ABBV-383) for AL amyloidosis
This study tests a new drug called etentamig (ABBV-383) given through a vein to see if it can control disease activity in people with AL amyloidosis who have already tried other treatments. It may help if your disease has progressed or is not responding well to prior therapies.
Miami, FloridaAges 18 years+ - NCT06203938Recruiting
Light therapy study for autism
This trial tests if non-invasive near-infrared light stimulation can help people with autism. It is open to individuals aged 4 to 60.
Austin, TexasAges 4–60 - NCT06215235Recruiting
Bright light therapy for depression in intellectual disability
This trial studies how bright light therapy (using a special lamp) is being used to help people with intellectual disabilities who have depression. It involves staff, family members, and patients to see how the therapy works in real life.
RotterdamAges 18 years+ - NCT06292780RecruitingPhase 1/Phase 2
Testing linvoseltamab for AL amyloidosis that came back
This trial tests a new drug called linvoseltamab for people with AL amyloidosis that has returned or is not responding to treatment. It aims to see if the drug is safe and helps control the disease.
Duarte, CaliforniaAges 18 years+ - NCT06376214Recruiting
Daratumumab for newly diagnosed light chain amyloidosis
This trial tests the drug daratumumab in people newly diagnosed with light chain amyloidosis that affects the heart, kidney, or liver. The goal is to see if daratumumab can help control the disease. Eligibility depends on your disease stage and overall health.
Nanjing, JiangsuAges 18–75 - NCT06418958Recruiting
Heat from dental light on healthy teeth
This trial measures how much the temperature rises inside a healthy tooth when a dental curing light is used. It helps dentists understand if certain light wavelengths could be safer for teeth.
Gainesville, FloridaAges 21–35 - NCT06485505RecruitingPhase 1
Isotretinoin vs light for nail fungus treatment
This trial compares two treatments for nail fungus (onychomycosis): a medication called isotretinoin and a special light therapy (excimer light) used alongside standard care. It aims to find which works better as an add-on treatment.
Zagazig, ZagazigAges 18–60 - NCT06491238Recruiting
Light vs. moderate exercise for myasthenia gravis
This study compares light exercise (like gentle walking) to moderate exercise (like brisk walking) for people with myasthenia gravis. It aims to see if one type of exercise is safer and more helpful for managing symptoms.
Saint Paul, MinnesotaAges 18–80 - NCT06525571RecruitingPhase 3
Blue light surgery for high-risk bladder cancer
This trial tests if using blue light during surgery helps remove all cancer in people with high-risk non-muscle invasive bladder cancer. It may lower the chance of the cancer coming back.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06655129Recruiting
Intense pulsed light for hair, acne, redness, or spots
This trial tests a light-based device (IPL) to treat unwanted hair, acne, redness (rosacea), or age spots. It may help if you are an adult with one of these skin concerns and have a lighter skin type (not very dark). The treatment is quick and gentle, with little downtime.
AuxerreAges 18 years+ - NCT06687304Recruiting
Lighting effects on radiographers in hospitals
This trial studies how lighting in a hospital environment affects radiographers. It aims to understand if different lighting designs can improve comfort, well-being, or performance at work.
Lund, Skåne CountyAges 21 years+ - NCT07508215Recruiting
Bright light therapy for memory problems in depression
This study tests whether daily bright light therapy can improve thinking and memory in people with major depression. You would continue your regular antidepressant and add 30-60 minutes of light box use each morning.
Beijing, Beijing MunicipalityAges 18–60 - NCT06717048Recruiting
Finding the best red light therapy for myopia in children
This study tests whether a special red light therapy can help slow down the progression of nearsightedness in children. It compares different amounts of light and how often it is used to find the best way to keep myopia from getting worse.
Shanghai, Shanghai MunicipalityAges 8–10 - NCT06720090RecruitingEarly Phase 1
Light therapy for obsessive-compulsive disorder (OCD)
This study tests whether morning light therapy can help people with OCD who have late bedtimes. It aims to improve symptoms by shifting your body's internal clock earlier.
St Louis, MissouriAges 17–35 - NCT06753773Recruiting
Red light therapy for short-term eye changes
This study tests if red light therapy can cause short-term changes in the back of the eye (the choroid and retina) in people with mild to moderate nearsightedness (myopia). It may help researchers understand if this therapy could be used to slow down or improve nearsightedness.
Hong KongAges 18–40 - NCT06850168Recruiting
Can special glasses slow down nearsightedness in children?
This trial tests a new type of spectacle lens designed to slow the progression of nearsightedness (myopia) in children. If your child is between 6 and 10 years old, has mild to moderate nearsightedness, and is willing to wear glasses full-time for two years, this study may be a good fit.
SingaporeAges 6–11 - NCT06916260Recruiting
Light therapy study for people with Parkinson's disease
This study tests whether light therapy can help people with Parkinson's disease. Participants will receive light therapy sessions and have their symptoms checked before, after, and three months later.
Newark, DelawareAges 50–80 - NCT06922409Recruiting
Light therapy for stroke recovery in rehabilitation
This trial tests whether exposure to naturalistic light can help reduce fatigue and depression after a stroke. It is designed for patients in a rehabilitation unit who are able to communicate and cooperate with simple physical exams.
Glostrup Municipality, Capital RegionAges 18 years+ - NCT06943625Recruiting
Green light and brain stimulation for migraine
This trial tests whether combining green light therapy with a gentle brain stimulation technique (transcranial direct current stimulation, or tDCS) can help reduce migraine pain. It may be an option for people with frequent migraines who have not found relief from other treatments.
Rawalpindi, Punjab ProvinceAges 18 years+ - NCT06967051Recruiting
Smartphone test of pupil response after cannabis use
This study uses a smartphone app to measure how your pupils react to light after using cannabis. It aims to see if the app can detect recent cannabis use, which could help develop a quick, non-invasive test.
London, OntarioAges 21 years+ - NCT06971380RecruitingPhase 2
CAR-T therapy for multiple myeloma and amyloidosis
This trial tests a new CAR-T cell treatment (HBI0101) for people with multiple myeloma or light-chain amyloidosis that has come back or stopped responding to other treatments. The therapy uses your own immune cells to fight cancer, and the goal is to see if it can help control the disease.
JerusalemAges 18 years+ - NCT06983951Recruiting
Study of CAR T cells for light chain amyloidosis
This trial tests a type of immunotherapy called CAR T cells that target a protein called BCMA on abnormal cells. It is for people whose light chain amyloidosis has come back or not responded to previous treatments.
Beijing, Beijing MunicipalityAges 18 years+
Hear when a new Light trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for light?
- Yes. Clin2 currently lists 277 recruiting light studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a light trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a light trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.